Here, to investigate the efficacy of tirzepatide in people with MC4R deficiency, we examined genetic data obtained from participants in a randomized controlled trial (SURMOUNT-1) of people with a BMI 30 kg m 2 , or 27 kg m 2 with at least one weight-related comorbidity 2 , treated with tirzepatide versus placebo
All conditions on this spectrum are strongly associated with metabolic risk factors like abdominal obesity, insulin resistance, diabetes, high blood pressure, and high cholesterol
What This Means for Our Practice Seven additional Phase 3 trials are expected in 2026, evaluating retatrutide across obesity, type 2 diabetes, sleep apnea, chronic low back pain, and MASLD
It is a food supplement that offers 250 mg of glutathione and 100 mg of vitamin C in each serving
Antioxidant Support NAC is a precursor to glutathione, one of the bodys most important antioxidants